ArticleLipids in health and disease2025
Novel lipid profiles and atherosclerotic cardiovascular disease risk: insights from a latent profile analysis.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The effect of olanzapine on lipid profiles in humans: a time and dose response meta-analysis of randomized controlled trials.BMC cardiovascular disorders · 2026Pooled it
- Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod PH20 in generalized myasthenia gravis: final results from a phase 3 open-label extension study (ADAPT-SC+).Frontiers in neurology · 2026Trial
- Artificial Intelligence in Cardiovascular Risk Prediction: An Up-to-Date Narrative Review on the Emerging Role of Lipid Profile-Based Models.Journal of clinical medicine · 2026Review
- Association Between Triglyceride/High-Density Lipoprotein Ratio and Premature Coronary Artery Disease in Young Saudi Population: A Case-Control Study.Diagnostics (Basel, Switzerland) · 2026Article
- Comparative effects of natural and functional lipid sources on physicochemical, textural, sensory, and nutritional lipid indices of spreadable processed cheese analogue.Scientific reports · 2026Article
- Latent Profiles of Modifiable Biological Factors and Their Associations with Lifestyle Factors and Cardiovascular Disease Outcomes.Journal of clinical medicine · 2026Article
- Article
- Identification of key cardiovascular disease predictive factors from the China Health and Retirement Longitudinal Study dataset using machine learning-based algorithms.Journal of translational medicine · 2026Article
- Diagnostic Potential of Metabolomic and Proteomic Biomarkers in Cardiology-A Narrative Review.Biomedicines · 2026Review
- Lipid ratios as early screening markers of dyslipidemia in normal-BMI university students: a cross-sectional epidemiologic study.Archives of medical sciences. Atherosclerotic diseases · 2026Article
- Two temporally validated diagnostic models for arterial stiffness using routine clinical indicators: a practical tool for resource-limited settings.Frontiers in endocrinology · 2026Article
- Effects of exercise snacks on physical and mental health among sedentary students: a randomized controlled trial study protocol.Frontiers in psychiatry · 2026Article
- Long-term lipoprotein and lipid profiles and association with metabolic risk markers in youth with perinatally acquired HIV and matched controls: a 10-year comparative cohort study.Lipids in health and disease · 2025Observational
- Association between lipid profiles and early clinical outcomes in acute ischemic stroke: a single-center cohort study in the Chinese population.BMC neurology · 2025Article
- Self-Perceived Fitness in Young Athletes: Associations with Anthropometric Markers and Lipid Profile as Cardiometabolic Risk Factors-COR-SCHOOL Study.Journal of functional morphology and kinesiology · 2025Article
- Apolipoproteins and high-density lipoprotein phospholipids as indicators of atherosclerotic cardiovascular disease in Nigeria.African journal of laboratory medicine · 2025Article
- A Cross-Sectional Study of the Association Between Uric Acid-to-High-Density Lipoprotein Cholesterol Ratio and Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDyslipidemia is a key contributor to atherosclerotic cardiovascular disease (ASCVD). Despite the well-established correlation between abnormal lipid metabolism and ASCVD, existing diagnostic and predictive models based on lipid indices alone or in combination often exhibit suboptimal sensitivity and specificity. There is an urgent need for improved lipid indicators or novel combinations thereof.
methodsThe study included 898 cardiology inpatients who underwent coronary angiography (CAG). A latent profile analysis (LPA) was utilized to delineate lipid profiles on the basis of four routine lipid indices (total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TG)) and the triglyceride‒glucose (TyG) index as a proxy for the TG. Logistic regression models were used to assess the correlations between lipid profiles and the occurrence and severity of coronary artery stenosis (CAS and severe CAS), as well as the occurrence of coronary heart disease (CHD). Predictive modeling subsequently validated the predictive power of the lipid profiles for cardiovascular outcomes.
resultsThe LPA delineated four distinct lipid profiles: Profile 1 (relatively high HDL with the lowest TC, LDL and TyG, 41.20%), Profile 2 (relatively high TC, LDL, and TyG with the lowest HDL, 36.42%), Profile 3 (relatively low TC, LDL and TyG with relatively high HDL, 18.93%), and Profile 4 (the highest TC, LDL, and TyG with the highest HDL, 3.45%). Profile 1 was associated with the lowest ASCVD risk, whereas Profile 2 posed the highest risk for all adverse outcomes. The risk associated with Profile 3 and Profile 4 varied depending on the outcome. Profile 4 presented a lower odds ratio (OR) for CAS than did Profile 3, whereas Profile 3 presented a lower OR for severe CAS and CHD. The lipid profile variable substantially outperformed individual lipid indices or their combinations in predicting cardiovascular outcomes.
conclusionsFour distinct lipid profiles were identified among patients, with a particular profile characterized by lower levels of TC, LDL, and TyG, as well as a lower HDL, emerging as the most predictive of adverse cardiovascular outcomes. This underscores the critical need for a thorough lipid profile analysis to pinpoint individuals at heightened risk for adverse cardiovascular outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.